Todas las investigaciones
ReclutamientoOBSERVACIONAL

Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

This study aims to find new and clearer ways to identify Polycystic Ovary Syndrome (PCOS) in young women aged 15-25. PCOS is a common condition affecting women's hormone levels. Researchers are checking specific markers in blood samples to see if they can help doctors diagnose PCOS more effectively. Currently, diagnosing PCOS can sometimes be tricky. By finding these new markers, the hope is to make it simpler and quicker for young women to get a diagnosis. This could lead to earlier treatment and better ways to manage the condition in the future, ultimately improving the health and well-being of those with PCOS.

De un vistazo

Estado
Reclutamiento
Patrocinador
University Hospital Erlangen
Objetivo de inscripción
380
Inicio
31 Ene 2023
Estimación de finalización
01 Mar 2027

¿De qué trata este estudio?

This research is looking into Polycystic Ovary Syndrome (PCOS), a common health problem that affects many women. PCOS can cause various symptoms, such as irregular periods, acne, and difficulty becoming pregnant. Right now, diagnosing PCOS can sometimes take time, as doctors often need to look at a combination of symptoms and test results.

The main goal of this study is to find clearer and more reliable ways to identify PCOS in young women aged 15 to 25. Scientists are focusing on 'biomarkers', which are like signals or clues found in your body, often in your blood, that can tell us about your health. By finding new biomarkers specific to PCOS, researchers hope to develop better tests that can help doctors diagnose the condition more easily and at an earlier stage.

Why does this matter? An earlier and more accurate diagnosis of PCOS can lead to quicker access to treatments and support, helping women manage their symptoms and overall health more effectively. This study is an important step towards improving how PCOS is understood and cared for in the future.

Puntos clave

  • A research study looking for better ways to diagnose Polycystic Ovary Syndrome (PCOS).
  • Focuses on young women aged 15-25.
  • Involves health checks and blood tests.
  • Aims to find new 'biomarkers' in blood to help with diagnosis.
  • Could lead to earlier and more accurate PCOS diagnosis in the future.

¿Quién puede ser elegible?

This study is particularly looking for young women aged between 15 and 25 years old. To take part, you'll need to be in this age group and be willing to provide your written consent, meaning you agree to participate after understanding what the study involves.

There are certain reasons why someone might not be able to join. For example, if you've only just started your periods (less than a year ago), or if you are currently using hormonal birth control, you wouldn't be able to participate. Also, if you are pregnant, or have certain types of major cysts or growths on your ovaries larger than 2cm (as seen on an ultrasound scan), or are undergoing treatment for cancer, this study wouldn't be suitable for you.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. Are you a female aged between 15 and 25 years?
  2. Have you had your periods for at least one year?
  3. Are you currently NOT using hormonal birth control?
  4. Are you NOT currently pregnant?
  5. Do you NOT have major ovarian cysts or growths (over 2cm)?
  6. Are you NOT receiving treatment for cancer?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you decide to take part in this study, your journey will start with an initial visit. During this visit, the research team will gather information about your health and medical history, which doctors call 'clinical data'. You will also have a blood sample taken. This blood sample will be checked for the biomarkers related to PCOS. If, based on your initial assessment, you are diagnosed with PCOS as part of the study, you'll be asked to come back for two follow-up visits. The first follow-up will be about three months after your initial diagnosis, and the second will be sometime between six and twelve months after your first visit. At these follow-up appointments, more blood samples will be taken, and additional health information will be collected to see how you are getting on with any treatment you might have started.

Riesgos y beneficios potenciales

Participating in this study might not directly benefit your health immediately, but the information gained could greatly help other women with PCOS in the future by improving diagnosis methods. The main risks involve the blood tests, which might cause some minor discomfort or bruising where the needle is inserted. Every effort will be made to ensure your comfort and safety. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Ubicaciones (1)

  • Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany
    Código postal verificado
    Erlangen, Germany· Reclutamiento

Preguntas comunes

What is PCOS?

PCOS stands for Polycystic Ovary Syndrome. It's a common condition affecting women's hormone levels, which can lead to symptoms like irregular periods, acne, or difficulty getting pregnant.

What are biomarkers?

Biomarkers are like internal signals in your body, often found in blood, that can give doctors clues about your health or a particular condition.

Will I get paid to join the study?

The information provided does not mention payment for participation. This is usually discussed by the research team if you are considering joining.

How many visits will I need to make?

You will have at least one visit. If you are diagnosed with PCOS during the study, you will have two additional follow-up visits over the next 6-12 months.

Will I receive treatment for PCOS if I'm diagnosed?

The study aims to improve diagnosis, but it does not specify providing treatment. However, if diagnosed, your doctors will discuss appropriate care options with you.

Cómo obtener más información

Laura Lotz, Dr. med.

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Stud…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.